Oxandrolone

NOVABOL Tablets by NovaTech Sciences contain high-purity Oxandrolone USP (CAS 53-39-4), an orally active anabolic compound recognized for its association with muscle maintenance, physical performance environments, and hormone balance applications. Oxandrolone is globally identified through CAS 53-39-4, ensuring compound authenticity, chemical traceability, and pharmaceutical-grade standardization across international healthcare markets.

NovaTech Sciences manufactures Oxandrolone USP CAS 53-39-4 under strict pharmaceutical quality control protocols designed to maintain compound purity, formulation consistency, and reliable global supply.

Oxandrolone, registered under CAS 53-39-4, is an orally active anabolic compound derived from dihydrotestosterone (DHT). It has been widely recognized for its stable anabolic characteristics and relatively low androgenic profile compared with some other androgenic compounds.

The CAS registry number 53-39-4 serves as the internationally recognized chemical identifier for Oxandrolone USP. This identifier ensures compound verification, regulatory transparency, and standardized pharmaceutical identification across manufacturing and distribution systems.

Through these mechanisms, Oxandrolone CAS 53-39-4 supports physiological processes associated with lean muscle preservation and physical performance environments.

One distinguishing characteristic of Oxandrolone is its minimal aromatization, meaning it does not significantly convert into estrogen. This property has contributed to its reputation for supporting lean muscle development with limited water retention.

Each production batch of Oxandrolone CAS 53-39-4 undergoes comprehensive analytical testing to confirm compound identity, purity verification, and dosage accuracy.

NovaTech Sciences operates as a trusted manufacturer, supplier, and exporter of pharmaceutical-grade anabolic compounds for international markets. By clearly specifying CAS 53-39-4, NOVABOL tablets maintain chemical authenticity and regulatory transparency.

These procedures ensure Oxandrolone USP tablets meet strict pharmaceutical distribution standards.

NovaTech Sciences emphasizes pharmaceutical precision, regulatory compliance, and compound reliability. NOVABOL tablets containing Oxandrolone CAS 53-39-4 are produced using advanced pharmaceutical technologies designed to maintain product stability and consistent formulation.

For pharmaceutical distributors and professional markets seeking a dependable source of Oxandrolone USP (CAS 53-39-4), NOVABOL Tablets by NovaTech Sciences provide verified compound identity, pharmaceutical manufacturing excellence, and reliable global supply. Supported by strict quality assurance systems, Oxandrolone CAS 53-39-4 remains a recognized anabolic compound associated with muscle maintenance, performance environments, and hormone balance applications.